Michael Heltzen insider trades: Exozymes (EXOZ) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Michael reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 26, 2026 | EXOZ | ↑ Buy | 855 | $7.49 | $6K | Direct | Sep 2, 2026 (7d) |
| Jul 2, 2025 | EXOZ | ↑ Buy | 1,040 | $10.22 | $11K | Direct | Jul 2, 2025 (0d) |
| Jan 17, 2025 | IZTC | ↑ Buy | 1,888 | $10.78 | $20K | Direct | Jan 21, 2025 (4d) |
| Nov 15, 2024 | IZTC | ↑ Buy | 1,984 | $11.10 | $22K | Direct | Nov 19, 2024 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other EXOZ insiders
Open-market trades in the last 12 months
About Michael Heltzen's insider trades
Michael Heltzen is Chief Executive Officer at Exozymes (EXOZ). Since Nov 15, 2024, Michael has reported 4 open-market purchases worth $59K and no sales on SEC Form 4. In the last 12 months: 1 buy ($6K).
Their filings also include grants and awards (2 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every EXOZ insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.